Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase. (Q33398675)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase.
scientific article

    Statements

    Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit